NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-127-2017-0-US-07 COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+
MALIGNANCIES 		US National Stage 16/612,495 11440963 Abandoned PDF
NCI E-520-2013-0-JP-17 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use JP DIV 2019-204306 Issued
NCI E-099-2014-0-JP-10 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2019-203937 Abandoned
NCI E-017-2017-0-SG-09 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES SG National Stage 11201910499V Pending
NCI E-127-2017-0-AU-03 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies AU National Stage 2018266103 Abandoned
NCI E-127-2017-0-JP-06 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies JP National Stage 2019-561944 Abandoned
NCI E-192-2020-0-US-01 USE OF STING AGONISTS TO AUGMENT CAR T CELL FUNCTION IN SOLID TUMORS US 62/932,913 Abandoned
NCI E-494-2013-0-JP-13 Methods of Preparing Anti-human Papillomavirus Antigen T Cells JP DIV 2019-202239 Issued
NHLBI E-200-2018-0-US-03 COMPOSITIONS AND METHODS FOR TREATING BETA-GLOBINOPATHIES US ORD 16/676,369 11325978 Issued PDF
NHLBI E-200-2018-0-PCT-02 NEW COMPOSITIONS AND METHODS FOR TREATING BETA-GLOBINOPATHIES PCT PCT PCT/US2019/060151 Expired
NCI E-264-2011-0-EP-10 Delivery Of Packaged RNA To Mammalian Cells EP DIV 19207297.3 Issued
NCI E-264-2011-0-GB-01 Delivery Of Packaged RNA To Mammalian Cells GB EP 19207297.3 Issued
NCI E-264-2011-0-LU-01 Delivery Of Packaged RNA To Mammalian Cells LU EP 19207297.3 Issued
NCI E-264-2011-0-CH-01 Delivery Of Packaged RNA To Mammalian Cells CH EP 19207297.3 Issued
NCI E-264-2011-0-IE-01 Delivery Of Packaged RNA To Mammalian Cells IE EP 19207297.3 Issued
NCI E-264-2011-0-DE-01 Delivery Of Packaged RNA To Mammalian Cells DE EP 19207297.3 Issued
NCI E-264-2011-0-BE-01 Delivery Of Packaged RNA To Mammalian Cells BE EP 19207297.3 Issued
NCI E-264-2011-0-FR-01 Delivery Of Packaged RNA To Mammalian Cells FR EP 19207297.3 Issued
NCI E-264-2011-0-NL-01 Delivery Of Packaged RNA To Mammalian Cells NL EP 19207297.3 Issued
NCI E-069-2017-0-US-03 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL US National Stage 16/611,098 11401544 Issued PDF
NIAID E-137-2018-2-KR-12 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response KR National Stage 10-2019-7032483 Pending
NCI E-079-2020-0-US-01 Immunotherapy With An Immuninotoxin and Immunostimulator US 62/927,753 Abandoned
NICHD E-138-2019-0-US-01 COMBINED PIKFYVE AND P38 MAP KINASE INHIBITION FOR TREATING CANCER US 62/927,966 Abandoned
NCI E-019-2014-2-US-03 COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT US CON 16/664,523 11692010 Issued PDF
NIAID E-001-2017-1-US-03 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US National Stage 16/608,386 11236151 Issued PDF
NCATS E-198-2016-0-US-04 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling US National Stage 16/608,489 11026947 Issued PDF
NCATS E-051-2020-0-PCT-02 Crystal Forms Of An ALK2 Inhibitor PCT PCT PCT/US2019/058062 Expired
NCI E-344-2013-0-AU-01 TEM8 Antibodies and Their Use AU DIV 2022200117 Issued
NHLBI E-152-2018-0-US-02 Fluorogen-binding RNA Aptamers US National Stage 16/608,127 11434490 Issued PDF
NCI E-344-2013-0-AU-17 TEM8 Antibodies and Their Use AU DIV 2019253864 Issued
NCATS E-262-2016-0-HK-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS HK EP 19131469.9 Abandoned
NCI E-166-2018-0-PCT-02 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS PCT PCT PCT/US2019/057833 Expired
NCI E-166-2018-0-US-04 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US ORD 16/662,808 Abandoned
NCI E-166-2018-0-TW-03 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS TW ORD 108138456 Pending
NCI E-520-2013-0-AU-09 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use AU DIV 2019203443 Issued
NCI E-185-2019-0-US-01 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors US 62/924,498 Abandoned
NIAID E-052-2017-4-US-47 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection US CON 16/659,426 11129905 Abandoned PDF
NCI E-160-2018-0-PCT-02 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION PCT PCT PCT/US2019/057268 Expired
NLM E-107-2010-2-US-29 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/658,195 Abandoned
NCI E-160-2018-0-EP-05 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION EP National Stage 19804901.7 Pending
NCI E-190-2014-0-JP-40 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		JP DIV 2019-191919 Abandoned
NCI E-160-2018-0-AU-03 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION AU National Stage 2019368218 Pending
NCI E-160-2018-0-CA-04 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION CA National Stage 3117390 Pending
NHGRI E-177-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS US 62/624,103 Abandoned
NHGRI E-178-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS US 62/924,143 Abandoned
NCI E-128-2017-0-US-04 DEVICE FOR STORING AND TRANSPORTING TISSUE SPECIMENS US National Stage 16/606,555 11623220 Issued PDF
NIAID E-187-2018-0-PCT-02 A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS PCT PCT PCT/US2019/057038 Expired
NIAID E-216-2018-2-PCT-01 Multi-Specific Antibodies For HIV-1 And Their Utility PCT PCT COMB PCT/US2019/057089 Expired
NIAID E-076-2015-4-US-01 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION US DIV 16/655,516 11173201 Issued PDF
NHGRI E-092-2014-1-US-06 SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS US DIV 16/655,004 Abandoned